Functional chimeric antigen receptors (CARs) against insulin in conjunction with FOXP3 can be used to modify naïve effector T cells to specific Treg cells in order to redirect their specificity towards T1D [79]. The gene discussed is INS; the disease is type 1 diabetes mellitus.